鹅细小病毒研究进展

小鹅瘟是由鹅细小病毒引起的一种急性、亚急性烈性传染病,是目前危害养鹅业的重要传染病之一。近年来关于鹅细小病毒的研究又有了新的发展和新的观点,作者从鹅细小病毒分子生物学、检测方法、致病机理和抗原位点的定位等方面进行了阐述。     

防治桑枝芽枯萎细菌病害药物室内药效测定初报

作者1995~1996年对征集到的20多种杀菌剂,对桑枝、芽枯萎细菌病病原细菌No:1、No:2号菌株,应用植物病原细菌室内药效测定常规方法——抑菌圈法进行筛选,最后得出硫酸链霉素、盐酸土霉素、代森铵、抗菌素402、新洁尔灭、波尔多液、甲醛共七种对供试菌株效力较强,其中硫酸链霉素、盐酸土霉素、代森铵、波尔多液、甲醛已在病区小区试验和大田防治效果良好.     

新发林麝环状类病毒的鉴定和分析

利用病毒宏基因组学(viral metagenomics)方法,本研究从95份林麝粪便样品中检测到1株新型圆环病毒样(Circovirus-like)病毒,经过拼接获得其全基因组序列,该毒株命名为ls-cyc.其基因组全长约3552 nt,GC含量39.00％,含有2个开放阅读框(ORF),即ORF1和ORF2.其中O...     

1株猪源牛病毒性腹泻病毒的分离与鉴定

从BVDV阳性仔猪病料中分离病毒,为开展猪源BVDV病原学研究奠定基础。将处理后BVDV阳性仔猪组织样品接种MDBK细胞,分离到1株猪源BVDV,命名为SD0803株。通过细胞培养、直接免疫荧光、5′-UTR与Npro PCR扩增、电镜观察、TCID50测定及对其分子进化特征加以分析。结果表明,该毒株在MDBK细胞上盲传至13代未出现细胞病变。在直接免疫荧光试验中呈阳性荧光信号。PCR扩增分别获得5′-UTR与Npro预期大小DNA片段。电镜观察,病毒粒子略呈圆形,有囊膜,直径约50nm。病毒滴度为10-6.5 TCID50.0.2 mL-1。SD0803 5′-UTR、Npro序列进化分析显示,该分离株属于BVDV-1,与已知BVDV-1各亚型之间同源性较低,单独成一分支。结果表明,成功分离鉴定1株猪源BVDV SD0803,该毒株为非致病变型BVDV-1,极有可能为BVDV-1新的亚型。     

家禽病毒性免疫抑制病的分析与对策

免疫抑制引起免疫失败及对病原的易感性增加，是目前乃至今后威胁家禽健康的最危险的潜在因素之一。作者阐述与讨论了几种目前常见的家禽病毒性免疫抑制病的概念、免疫抑制机理及防制措施，以此引起同行对该病的进一步重视。     

应用于兽用疫苗研发的病毒载体研究进展

对应用于兽用疫苗研发的病毒载体,包括痘病毒载体、疱疹病毒载体、腺病毒载体、杆状病毒载体、副粘病毒载体、弹状病毒载体、甲病毒载体、冠状病毒载体、反转录病毒载体、黄病毒载体等DNA和RNA病毒载体的研究进展进行了综述,以期为我国基因工程活载体疫苗研发工作提供参考.     

Development of a leukocytopenic baby guinea pig model with azathioprine and cyclophosphamide

Immunosuppressive agents were given to baby guinea pigs to develop a leukocytopenic baby guinea pig model. Azathioprine in different doses, and cyclophosamide and methylprednisolone combinations did not result in predictable leukocytopenia without significant mortality. A combination of azathioprine 20mg and cyclophosphamide 20mg administered once daily for 5 days to 42 baby guinea pigs resulted in a mean white blood cell count of 2531/mm³ ±1198 (a reduction of 3931 ± 1413 from pretreatment values). The mean counts for polymorphonuclear leukocytes and lymphocytes on day 6 were 398/mm³ and 2035/mm³, respectively. Only 7% mortality was seen in these animals. This model can be utilized to study a variety of bacterial and viral infections in “immunocompromised hosts”.     

Equine viral arteritis (EVA): A potential trapdoor for the practicing veterinary surgeon in the United Kingdom

Equine viral arteritis (EVA) is a notifiable disease in the UK with potentially serious consequences for horse owners and breeders. Legislation exists under ‘The Equine Viral Arteritis Order 1995’ to protect the UK from this contagious equine disease. The UK is at risk of introduction of EVA through importation of infected horses or semen. There is however much misunderstanding regarding the importance of EVA and occasionally misinterpretation, specifically on how to protect and manage stallions with vaccination. Issues with changing vaccine datasheet recommendations and vaccine availability have resulted in stallions being inappropriately vaccinated or vaccinations lapsing. This article is aimed at the practicing veterinary surgeon, to update them as to the current status of EVA vaccination and disease screening in horses in the UK and how to avoid some common pitfalls.